Disclosures for "Development of a Tool for Community Deployment That Detects ALS and Other Neurodegenerative Diseases"
-
Miss Nigam has nothing to disclose.
-
Miss Naughton has nothing to disclose.
-
Ms. Castro-Ariza has nothing to disclose.
-
Ms. Mansoor has nothing to disclose.
-
Ms. Weaver has nothing to disclose.
-
Miss Enriquez has nothing to disclose.
-
Dr. Cincotta has received research support from the NIH.
-
Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Heiman-Patterson has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Heiman-Patterson has received research support from MTPA. The institution of Dr. Heiman-Patterson has received research support from State of Pennsylvania . The institution of Dr. Heiman-Patterson has received research support from ALS Association. The institution of Dr. Heiman-Patterson has received research support from ALS United. The institution of Dr. Heiman-Patterson has received research support from ALS Hope Foundation.